Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    InternationalInternational
    • Country/Region
    • We guide you
      • Fertility
        • What to do if…
      • Prevent Inherited Diseases
        • Carrier Genetic Test
      • Worry-free Pregnancy
        • NACE
        • Prenatal Diagnostics
        • Newborn Health
    • Reproductive Health
      • Specialists
        • ALICE
        • EMMA
        • ERA
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • Zenit
        • PGT-A
        • PGT-M
        • POC
        • SAT
        • Newborn Screening
      • Patients
        • ALICE
        • EMMA
        • ERA
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • Zenit
        • PGT-A
        • PGT-M
        • SAT
        • POC
    • Diagnostics
    • About us
      • Igenomix Research
      • About Igenomix
    • Academy
    • Blog
        Genomics Precision Diagnostic > Pulmonology > Idiopathic Pulmonary Fibrosis

        Idiopathic Pulmonary Fibrosis

        Idiopathic Pulmonary Fibrosis (IPF) is a specific form of chronic, progressive lung disease defined as the presence of progressive lung scarring in the form of fibrosing interstitial pneumonia of unknown cause with the histopathological finding of usual interstitial pneumonia (UIP).
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Idiopathic Pulmonary Fibrosis (IPF) is a specific form of chronic, progressive lung disease defined as the presence of progressive lung scarring in the form of fibrosing interstitial pneumonia of unknown cause with the histopathological finding of usual interstitial pneumonia (UIP). Although the etiology is unknown, there probably is an effect of endogenous and exogenous micro-environmental factors in subjects together with genetic predisposition. All of this causes repetitive micro-injury to the lung tissue and vasculature, triggering and inflammatory response and ultimately fibrosis. It occurs primarily in older adults, and the progressive lung scarring over time results in reduced oxygen intake.  

        • The Igenomix Idiopathic Pulmonary Fibrosis Precision Panel can be used as a diagnostic tool ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes. 

        Indication

        The Igenomix Idiopathic Pulmonary Fibrosis Precision Panel is indicated in those cases where there is a clinical suspicion of IPF with or without the following manifestations during at least six months:  

        • Weight loss 
        • Low-grade fevers 
        • Fatigue 
        • Arthralgias (articular pain) 
        • Myalgias (muscular pain) 
        • Gradual onset shortness of breath with exertion 
        • Non-productive cough 

        Clinical Utility

        The clinical utility of this panel is:  

        • The genetic and molecular diagnosis for an accurate clinical diagnosis and improve prognosis. 
        • Early initiation of treatment with a multidisciplinary team for treatment of comorbid medical conditions as well as initiate early supportive treatment, surgical treatment and regular surveillance of pulmonary function.   
        • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 

        Genes & Diseases

        Methodology

        References

        See scientific referrals

        Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017). Idiopathic pulmonary fibrosis. Nature reviews. Disease primers, 3, 17074. https://doi.org/10.1038/nrdp.2017.74 

        Sgalla, G., Iovene, B., Calvello, M., Ori, M., Varone, F., & Richeldi, L. (2018). Idiopathic pulmonary fibrosis: pathogenesis and management. Respiratory research, 19(1), 32. https://doi.org/10.1186/s12931-018-0730-2 

        Xaubet, A., Ancochea, J., & Molina-Molina, M. (2017). Idiopathic pulmonary fibrosis. Fibrosis pulmonar idiopática. Medicina clinica, 148(4), 170–175. https://doi.org/10.1016/j.medcli.2016.11.004 

        Sharif R. (2017). Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines. The American journal of managed care, 23(11 Suppl), S176–S182. 

        Glass, D. S., Grossfeld, D., Renna, H. A., Agarwala, P., Spiegler, P., Kasselman, L. J., Glass, A. D., DeLeon, J., & Reiss, A. B. (2020). Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches. Respiratory investigation, 58(5), 320–335. https://doi.org/10.1016/j.resinv.2020.04.002 

        Idiopathic Pulmonary Fibrosis NGS Panel – Tests – GTR – NCBI. (2021). Retrieved 22 February 2021, from https://www.ncbi.nlm.nih.gov/gtr/tests/324884.5/ 

        Raghu, G., Collard, H., Egan, J., Martinez, F., Behr, J., & Brown, K. et al. (2011). An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. American Journal Of Respiratory And Critical Care Medicine, 183(6), 788-824. doi: 10.1164/rccm.2009-040gl 

        descargar

        Detail description

        Download

        Request Information


        WE GUIDE YOU

        Fertility
        Inherited diseases prevention
        Healthy pregnancy

        To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

        OUR SERVICES

        Genetic solutions
        For patients
        How to send a sample?
        User manual

        ABOUT US

        About Igenomix
        Contact
        Quality
        Complaints
        Work with us

        FOLLOW IGENOMIX

          + 96 390 53 10
          Write us
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        Country/Region

        [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

        Request Information


        • We guide you
          • Fertility
            • What to do if…
          • Prevent Inherited Diseases
            • Carrier Genetic Test
          • Worry-free Pregnancy
            • NACE
            • Prenatal Diagnostics
            • Newborn Health
        • Reproductive Health
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • Zenit
            • PGT-A
            • PGT-M
            • POC
            • SAT
            • Newborn Screening
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • Zenit
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • Diagnostics
        • About us
          • Igenomix Research
          • About Igenomix
        • Academy
        • Blog
        • Country/Region
        • +34 96 390 53 10
        • Clinic Portal
        • Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        International
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

        3rd Party Cookies

        This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

        Keeping this cookie enabled helps us to improve our website.

        Please enable Strictly Necessary Cookies first so that we can save your preferences!

        Cookie Policy

        More information about our Cookie Policy